U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07125209) titled 'Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer' on Aug. 07.
Brief Summary: The purpose of this research is to assess several components of cognition in patients recently diagnosed with advanced epithelial ovarian cancer and who will be undergoing neoadjuvant chemotherapy for treatment of the cancer. 18 participants will be enrolled and can expect to be on study for approximately 10 months.
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition:
Ovarian Cancer
Cognitive Change
Intervention:
OTHER: Patient Reported Outcomes Assessment
Functional Assessment of Cancer Therapy - Ovarian (FACT-O) and Func...